Burlington, MANCT04743765Now EnrollingIRB Ready

Hip Fractures Clinical Trial in Burlington, MA

Access cutting-edge hip fractures treatment through this clinical trial at a research site in Burlington. Study-provided care at no cost to qualified participants.

Sponsored by Population Health Research Institute

Quick Self-Assessment

See if you qualify for this Burlington location

Preparing your pre-screening questions…

Expert Care in Burlington

Access hip fractures specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related hip fractures treatment provided free

Apply for This Burlington Location

Check if you qualify for this hip fractures clinical trial in Burlington, MA

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Burlington

    Convenient for MA residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Burlington site if eligible
  4. 4Begin participation

About This Hip Fractures Study in Burlington

The HIP ATTACK-2 trial is a multicentre, international, parallel group randomized controlled trial to determine whether accelerated surgery for hip fracture in patients with acute myocardial injury is superior to standard care in reducing death at 90 days after randomization. The trial will also assess secondary outcomes at 90 days after randomization: inability to independently walk 3 metres, time to first mobilization (first standing and first full weight bear), composite and individual assessment of major complications (e.g., mortality, non-fatal myocardial infarction, acute congestive heart failure, and stroke), delirium, length of stay, pain, and quality of life.

Sponsor: Population Health Research Institute

Who Can Participate

Inclusion Criteria

age ≥45 years;
diagnosis of hip fracture during working hours with a low-energy mechanism requiring surgery;
troponin elevation ( at least one troponin measurement above the upper limit of normal occurring from the time of hip fracture to the time of randomization); and
informed consent.

Exclusion Criteria

taking a therapeutic dose of an anticoagulant for which no reversing agent is available and the anesthesiologist or surgeon believe surgery within 6 hours of eligibility criteria met would not be safe;
patients on a therapeutic vitamin K antagonist with a history of heparin induced thrombocytopenia (HIT);
patients with peri-prosthetic fracture, open fracture or bilateral fractures;
patients requiring an emergency surgery for another reason (e.g., subdural hematoma);
patients with acute myocardial infarction deemed to be clinically unstable, with a mechanical complication (i.e., acute papillary muscle rupture, ventricular septal defect), ST elevation myocardial infarction, or cardiogenic shock;
patients refusing consent; or
patients previously enrolled in HIP ATTACK-2.

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Burlington?

Yes, this clinical trial (NCT04743765) has an active research site in Burlington, MA that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Hip Fractures Treatment Options in Burlington, MA

If you're searching for hip fractures treatment options in Burlington, MA, this clinical trial (NCT04743765) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Burlington research site is actively enrolling participants for this clinical trial. You'll receive care from experienced hip fractures specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all hip fractures clinical trials near you to find additional studies recruiting in your area.

More Rheumatoid Arthritis Trials in Burlington, MA

See all rheumatoid arthritis clinical trials recruiting in Burlington — not just this study.

Browse Rheumatoid Arthritis Trials in Burlington

Browse More Trials by Condition

Ready to Join in Burlington?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Burlington, MA